AUTH/3813/8/23 – Complainant v AstraZeneca
Alleged off licence promotion of Tagrisso (osimertinib) to the public via LinkedIn
-
Received23 August 2023
-
Case numberAUTH/3813/8/23
-
StatusBreach ruled, case report pending